Ovarian Clear Cell Carcinoma

• CLINICAL_TRIALS research · 2026-03-18
  Clinical Trial Update: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) [Phase 3]

  Phase 3 clinical trial evaluating Olvi-Vec in combination with platinum-doublet chemotherapy and Bevacizumab versus physician's choice of ch…

• CLINICAL_TRIALS research · 2026-01-30
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma [Phase 2]

  A Phase 2 clinical trial evaluating the efficacy and safety of CYH33 in patients with recurrent/persistent ovarian clear cell carcinoma.

• CLINICAL_TRIALS research · 2025-12-16
  Clinical Trial Update: Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer [Phase 2]

  Phase 2 study evaluating pembrolizumab in combination with lenvatinib for ovarian clear cell carcinoma; the trial is currently active but no…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma [Phase 2]

  This is a Phase 2 clinical trial update evaluating liposomal irinotecan in combination with sintilimab and anlotinib for recurrent or persis…

• CLINICAL_TRIALS research · 2025-08-08
  Clinical Trial Update: A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer [Phase 1]

  Nuvectis Pharma's NXP800 is being studied in a Phase 1 trial for advanced solid tumors with expansion into ovarian cancer, and the study is …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-07-08
  Clinical Trial Update: RC48 in Combination With AK104 and Bevacizumab in OCCC [Phase 2]

  Phase 2 clinical trial evaluating RC48 in combination with AK104 and bevacizumab for ovarian cancer, including ovarian clear cell carcinoma,…

• CLINICAL_TRIALS research · 2025-06-03
  Clinical Trial Update: INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma [Phase 3]

  A Phase 3 clinical trial investigating QL1706 in combination with bevacizumab for advanced first-line ovarian clear cell carcinoma; the stud…

• CLINICAL_TRIALS research · 2025-05-15
  Clinical Trial Update: A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]

  Clinical trial update for Tulmimetostat DZR123 (CPI-0209) in adults with advanced solid tumors and various lymphomas. The study is in Phase …

• CLINICAL_TRIALS research · 2024-09-04
  Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing

  Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…

• CLINICAL_TRIALS research · 2024-08-13
  Clinical Trial Update: A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

  This clinical trial update describes a real-world study evaluating treatments for ovarian clear cell carcinoma. It is currently recruiting a…